Geneos Wealth Management’s JPMorgan US Quality Factor ETF JQUA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24M Buy
331,532
+26,046
+9% +$1.77M 0.49% 45
2026
Q1
$18.7M Buy
305,486
+23,003
+8% +$1.46M 0.43% 52
2025
Q4
$17.8M Buy
282,483
+12,785
+5% +$803K 0.44% 51
2025
Q3
$17M Buy
269,698
+18,997
+8% +$1.17M 0.43% 52
2025
Q2
$15.1M Buy
250,701
+125,320
+100% +$7.16M 0.37% 65
2025
Q1
$7.08M Buy
125,381
+12,322
+11% +$720K 0.24% 103
2024
Q4
$6.47M Buy
113,059
+3,219
+3% +$187K 0.23% 100
2024
Q3
$6.21M Buy
109,840
+10,066
+10% +$546K 0.24% 102
2024
Q2
$5.28M Buy
99,774
+6,182
+7% +$320K 0.23% 95
2024
Q1
$4.95M Buy
93,592
+20,098
+27% +$1.01M 0.23% 115
2023
Q4
$3.52M Buy
73,494
+21,283
+41% +$956K 0.17% 145
2023
Q3
$2.26M Buy
52,211
+24,810
+91% +$1.11M 0.12% 196
2023
Q2
$1.21M Buy
27,401
+13,651
+99% +$574K 0.06% 282
2023
Q1
$567K Buy
+13,750
New +$552K 0.03% 418

Other funds holding JQUA

Geneos Wealth Management's JQUA Position: Q2 2026 in Review

Geneos Wealth Management increased its JPMorgan US Quality Factor ETF (JQUA) stake by 8.5% in Q2 2026, buying an estimated $1.77M and bringing the position to 331,532 shares worth $24M. The position accounts for 0.49% of the portfolio, ranked #45.

Geneos Wealth Management first reported a position in JQUA in Q1 2023 and has held it in 14 quarters since. 478 funds tracked by Wall St. Rank hold JQUA as of Q2 2026.

  • Geneos Wealth Management held 331,532 shares of JPMorgan US Quality Factor ETF worth $24M as of Q2 2026.
  • Geneos Wealth Management bought 26,046 JPMorgan US Quality Factor ETF shares in Q2 2026, an estimated $1.77M.
  • JPMorgan US Quality Factor ETF made up 0.49% of Geneos Wealth Management's portfolio in Q2 2026, its #45 holding.
  • Geneos Wealth Management first reported a position in JPMorgan US Quality Factor ETF in Q1 2023 and has held it in 14 quarters since.
  • 478 funds tracked by Wall St. Rank held JPMorgan US Quality Factor ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.